(Q36928663)

English

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial

scientific article published on 24 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

multicenter clinical trial

0 references

pelvic inflammatory diseases

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J D C Ross

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

H S Cronjé

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

T Paszkowski

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

I Rakoczi

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

D Vildaite

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A Kureishi

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

M Alefelder

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

P Arvis

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

P Reimnitz

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

MAIDEN Study Group

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

24 May 2006

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sexually Transmitted Infections

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

82

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

446-451

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

In vitro activity of BAY 12-8039, a new fluoroquinolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

29 September 2017

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

27 June 2018

Adherence to oral therapies in pelvic inflammatory disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

4 September 2018

Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

4 September 2018

Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

4 September 2018

The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563874

4 September 2018

Pelvic inflammatory disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and clinical evaluation of levofloxacin in obstetrical and gynecological field

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European guideline for the management of pelvic inflammatory disease and perihepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/STI.2005.019109

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36928663&oldid=1663589064"